Genedrive PLC Director/PDMR Shareholding (9597B)

TIDMGDR

RNS Number : 9597B

Genedrive PLC

04 February 2020

genedrive plc

("genedrive" or the "Company")

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that today David Budd, Chief Executive Officer, acquired 43,330 ordinary shares of 1.5p each ("Ordinary Shares") in the Company at a price of 11.5p per share and Chris Yates, Non-Executive Director, acquired 25,000 Ordinary Shares at 11.56p per share.

Following these purchases, David Budd is interested in 188,710 Ordinary Shares, 0.5% of the issued share capital of the Company, and Chris Yates is interested in 41,304 Ordinary Shares, 0.1% of the issued share capital of the Company.

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 
            1.   Details of the person discharging managerial responsibilities 
                  / person closely associated 
      a.         Name                                       1. David Budd 
                                                             2. Chris Yates 
                ------------------------------  ------------------------------------- 
            2.   Reason for the notification 
                --------------------------------------------------------------------- 
            a.   Position/status                      1. Chief Executive Officer 
                                                       2. Non-Executive Director 
                ------------------------------  ------------------------------------- 
            a.   Initial notification            Initial notification 
                  /Amendment 
                ------------------------------  ------------------------------------- 
      3.         Details of the issuer, emission allowance market participant, 
                  auction platform, auctioneer or auction monitor 
                --------------------------------------------------------------------- 
            a.   Name                            genedrive plc 
                ------------------------------  ------------------------------------- 
            b.   LEI                             213800ZYODIRZ87Y4K14 
                ------------------------------  ------------------------------------- 
            4.   Details of the transaction(s): section to be repeated for 
                  (i) each type of instrument; (ii) each type of transaction; 
                  (iii) each date; and (iv) each place where transactions 
                  have been conducted 
                --------------------------------------------------------------------- 
            a.   Description of                  Ordinary shares of 1.5 pence each 
                  the 
                  Financial instrument, 
                  type 
                  of instrument                   GB00B1VKB244 
                  Identification 
                  code 
                ------------------------------  ------------------------------------- 
            b.   Nature of the                              Purchase 
                  transaction 
                ------------------------------  ------------------------------------- 
            c.   Price(s) and                             Price(s)         Volume(s) 
                  volume(s)                               1. 11.50p         1. 43,330 
                                                          2. 11.56p         2. 25,000 
                                                                     ---------------- 
                ------------------------------  ------------------------------------- 
            d.        Aggregated information 
                        *    Aggregated volume     N/A 
 
 
                        *    Price 
                ------------------------------  ------------------------------------- 
            e.   Date of the transaction         2020-02-04 
                ------------------------------  ------------------------------------- 
            f.   Place of the                    London Stock Exchange, AIM 
                  transaction 
                ------------------------------  ------------------------------------- 
 

For further details please contact:

 
 genedrive plc                                                               [phone] 
 David Budd: CEO / Matthew Fowler: 
  CFO 
 
 Peel Hunt LLP (Nominated Adviser and 
  Joint Broker)                                                              [phone] 
 James Steel / Oliver Jackson 
 
            Stanford Capital Partners Limited 
             (Joint Broker)                                                  [phone] 
            Patrick Claridge / John Howes 
 
 Walbrook PR Ltd (Media Relations &              [phone] or [e-mail] 
  Investor Relations) 
                                                               [phone] / +44 (0)7876 
 Paul McManus / Anna Dunphy                                                              741 001 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHEAKALEAFEEFA

(END) Dow Jones Newswires

February 04, 2020 11:25 ET (16:25 GMT)